MBIO Mustang Bio
- 0.3010
- -0.0168-5.29%
- 0.3184
- +0.0174+5.78%
Mustang Bio News
12 Health Care Stocks Moving In Friday's After-Market Session
GainersNeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (
Express News | Mustang Bio Announces Closing of $4 Million Public Offering
Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants
Mustang Bio (MBIO) said Monday it has priced a public offering of about 16.9 million common shares along with series A-1, A-2 and A-3 warrants to purchase three separate tranches of up to about 16.9 m
LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues
The Australian-based biopharma company MindBio Therapeutics Corp. (CSE:MBIO) obtained regulatory approval for a series of clinical trials in women's health using its proprietary LSD drug, MB22001. Th
Reported Earlier, Mustang Bio Prices $4M Public Offering Of 16,877,638 Shares Of Common Stock At $0.237/Share
Mustang Bio announced the pricing of a public offering of an aggregate of 16,877,638 shares of its common stock (or common stock equivalents in lieu thereof), Series A-1 warrants to purchase up to 16,
Express News | Mustang Bio Inc- Pricing of Public Offering of Aggregate of 16.88 Mln Shares, Warrants at Combined Price of $0.237 per Share and Warrant
Mustang Bio's Offering of 16.9 Million Shares and Warrants Prices at Combined Price of 23.7 Cents a Share and Warrant >MBIO
Mustang Bio's Offering of 16.9 Million Shares and Warrants Prices at Combined Price of 23.7 Cents a Share and Warrant >MBIO
Express News | Mustang Bio Announces Pricing of $4 Million Public Offering
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
Express News | Mustang Bio Files For Offering Of Up To 15.6M Shares Of Common Stock, Together With Accompanying Warrants
Express News | Mustang Bio Inc Files for Offering of up to 15.6 Mln Shares of Common Stock, Together With Accompanying Warrants
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) share
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. SINTX Techs (NASDAQ:SINT)
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersTrevena (NASDAQ:TRVN) shares increased by 27.0% to $0.51 during Wednesday's after-market session. The company's market cap stands at $9.2 million. Mustang Bio (NASDAQ:MBIO) stock increased by 1
Mustang Bio Stock Tumbles 27% Amid News of Mass Layoffs
Stocks to Watch: Medical Properties Trust, KULR Technology, Mustang Bio
By Ben Glickman Medical Properties Trust said it had agreed to sell its interest in five Utah hospitals to a new joint venture for $886 million. Combined with a payment from the joint venture to the
Express News | Mustang Bio Inc Approved A Reduction Of Its Workforce By ~81% Of Its Employee Base; Workforce Reduction Will Take Place Primarily In April 2024, Expected To Be Substantially Completed In Q2 Of 2024; Continue To Evaluate All Strategic And Other Alternative
Express News | Mustang Bio Inc: Continue to Evaluate All Strategic and Other Alternatives Related to Business
Express News | Mustang Bio Inc: Workforce Reduction Expected to Be Substantially Completed in Q2 of 2024
Express News | Mustang Bio Inc: Workforce Reduction Will Take Place Primarily in April 2024
Analysis
Price Target
No Data
